The Best Answer for Cancer: Notes from the 2020 Virtual Conference

The Best Answer for Cancer Conference was held virtually in 2020. It included three days of insightful presentations pertaining to cancer, COVID-19, chronic disease, DNA methylation, viral and fungal infections, ozone, and case studies. The information shared was cutting edge and beneficial to practitioners and to patients.

The presentations included:

  • Virginia Von Schaefer, MD: Salicinium and Synergy for Integrative Cancer Treatments
  • Constantine “Gus” Kotsanis, MD: Navigation Through a Patient’s Life from Cancer and Chronic Disease to Healing
  • Juergen Winkler, MD: 1) Anaerobic-Dysaerobic States: An assessment Tool for Better Caring for Your Patients 2) My COVID-19 Experience
  • David Minkoff, MD: Solving Complex Illness and Cancer Cases Using the Full Gamut of Biological Medicine Concepts
  • Jane McLelland: How to Starve Cancer Naturally with Off Label Drugs
  • Robert Thompson, MD: DNA Methylation: Aging, Cancer Prevention, Early Detection and Treatment
  • Doug Kaufmann: Similarities Between Viral and Fungal Infections
  • Michelle Schrader, MD and Jennifer Gramith, ND: Planting Seeds of Empowerment
  • Allan Magaziner, DO: Regenerative Medicine in Reversing Chronic Degenerative Diseases
  • Jonathan Murphy, MD: Approach and Experience with Non-Hodgkin’s Lymphoma
  • John Hall, PhD: Plant Extracts Effective Against Pancreatic Cancer Stem Cells
  • Robert Rowen, MD: Ozone Therapy for Coronavirus
  • Peih F. Chiang, ND: Effects of a Heart Rate Variability Intervention in Ovarian Cancer Survivors-A Pilot Study
  • Lance Grindle, MD: DMSO and Hematoxylin as a Cancer Treatment
  • Leigh Erin Connealy, MD: Patient Case Studies in Early and Advanced Stages of Detection, Treatment and Prevention of Cancer using Integrative Functional Medicine.

Following is a review of several of the presentations.

Similarities Between Viral and Fungal Infections

Doug Kaufmann, the host of the popular TV show, Know The Cause, became interested in the subject of fungus as it pertains to disease while working in the area of food allergy.

Review of Doug Kaufmann’s presentation

Why don’t we have a handle on COVID-19? Could it be because we are not looking at mycology or mold? Fungicomes come in millions of species. 300 are known to be pathogens for humans. They produce mycofungal poisons which can injure tissues. What does virology and mycology have in common? Gene fusion. This is a hybrid gene from two separate genes. Mycotoxins can induce hybrid genes. Viral genes plus fungal genes can fuse and be very hard to treat. Fungus involvement can cause gene mutations. Fungal convergence on a virus could be involved in COVID-19.

In Wuhan, scientists who were investigating bats in caves were exposed to a fungus that was in bat guano when they were testing fecal samples. This fungus is called Histoplasma capsulatum. When inhaled, this can cause histoplasmosis which is life threatening in immunocompromised people, especially the elderly. The incubation and symptoms mimicked COVID-19. What was the connection between these scientists and the result? The scientists returned to the lab from the caves covered in Histoplasma capsulatum and began testing bat guano for the presence of the virus that causes COVID-19. The DNA RNA possibly fused.

As far as cancer goes, gene fusion induces cancer metastasis. When a white blood cell and cancer cell fuse it creates a hybrid. They share their DNA and form a lump. The fungi can hide from the immune system in a lump. The same results can look like COVID-19 with volatile organic compounds. Is it COVID-19 or histoplasmosis? Could it be that the virus that causes COVID-19 fuses with the fungus so as to bypass the immune system and create severe symptoms that hide from the immune system?

In the case of histoplasmosis, the fungus needs sugars. To starve the fungus eat vegetables, meats, some fruits, but no grains or sugars.

There are many similarities between COVID-19 and histoplasmosis. People get sick by inhaling the virus or fungus. Those with compromised immunity are more vulnerable. The incubation period is identical (2-17 days). Both can cause Adult Respiratory Distress Syndrome (ARDS). Both can cause systemic disorders. Both share near identical symptoms.

Currently, Dyflucan or Nystatin was used by no one. Maybe we should look at antifungals for two weeks with COVID-19 according to Kaufmann.

Mycoviruses were first discovered in 1962. They infect fungi. Like viruses that infect animals and plants, mycoviruses require the living cells of other organisms to replicate. Fungi provide those living cells. Mycoviruses have been detected in all of the major phyla of fungi. If it is an RNA virus you now have an RNADNA hybrid that forms. When we treat with only antivirals, we are addressing the virus but not the fungal component.

To bring it full circle, hybrid structures occur with genetic fusion. RNA DNA hybrids are implicated in a multitude of biological processes. Loss of certain RNA processing factors in eukaryotic cells is associated with increased formation of co-transcriptional RNA-DNA hybrid structures known as R-loops, resulting in double strand breaks and DNA damage.

If COVID-19 is a hybrid disease, maybe we should be using an antifungal, Nystatin, which was developed in the 1950s. Genetic fusion enables two independent organisms to merge their DNA and RNA and form a new hybrid nucleic acid the likes of which no one would understand. COVID-19 RNA plus Histoplasma DNA equals hybrid.

When a human and fungal cell merge the fungal cell become the dominant cell. Why doesn’t phagocytosis destroy histomycosis? In the case of fungal infections, sometimes phagocytosis fails. In tissue, yeast cells of Histoplasma capsulatum (ascomycete) are found within macrophages (white blood cells) only. However, phagocytosis (cell death) does not always lead to killing and the intracellular habitat paradoxically results in protection of the fungus from other defenses of the host.

Five major cancers are increased with the use of lots of antibiotics including breast, prostate, and lymphoma. IV Vitamin C, Vitamin D3, and zinc, can help. Psoriasis that doesn’t respond to cortisone or UV light sometimes responds with the use of antifungals for two weeks. In addition, it is important to clear the diet of alcohol and sugar. The antifungals have proven their effectiveness in either inhibiting angiogenesis or inducing cancer cell apoptosis. Antibiotics or antivirals do not do this. Lamasil and Sporanox are used to treat nail fungus. Sporanox, Lamisil, Amphotericin B, Nystatin, Griseofulvin, Thiabendazole are all antifungals.

It could be beneficial to assume fungus is involved until proven otherwise. When fungus is treated and dies, the mycotoxins are released. So the patient can feel badly as the die off happens. This is expected and is an indication the therapy is working. With Nystatin, Kaufmann recommends beginning with a small pediatric dose and gradually increasing the dose. These antifungals, when appropriate, should be used for only a short time. In order to help the patient, IV’s of Myers Cocktail and Vitamin C are helpful.

The CDC published in 2017 the following: “Fungal diseases like Valley Fever or blood stream candida infections (candidemia) can cause serious illness and even death. Inhaling fungus causes many fungal diseases. Hospitals, certain prescribed drugs, and having impaired immunity, among other things, increases vulnerability to fungus. Because fungal diseases mimic other diseases, fungal diagnoses are often delayed. If you are not getting better talk to your doctor about fungal disease.”

For more information go to: Doug Kaufmann's Know the Cause.

Regenerative Medicine in Reversing Chronic Degenerative Disease

As founder and medical director of the Magaziner Center for Wellness, Dr. Allan Magaziner has been at the forefront of regenerative and cellular medicine.

Review of Dr. Allan Magaziner, DO presentation

Dr. Magaziner introduced two new modalities other than stem cells and PRP. Exosome therapy and therapeutic peptides are a new and evolving field.

Neurodegeneration needs neuro-regeneration. Exosomes therapy and peptides are the new option. Exosomes are given via IV. Immune dysfunction is related to many chronic illnesses. As we age, Reactive Oxygen Species (ROS) inflammation, mitochondrial dysfunction, cell senescence (when cell division doesn’t happen properly), lack of cell signaling and communication and lack of cellular repair occurs.

Exosomes are fluids secreted from the cells. These are very tiny, about the same size as a virus, and are present in most body fluids in extracellular vesicles. They target and transfer their cargo from donor to receptor cells to trigger phenotypic changes. They play a critical role in intracellular signaling and communication and help restore homeostasis. Exosomes are found in all fluids of the body, contain growth factors, proteins, cytokines, mRNA and miRNA to alter the function of target cells. These substances may account for the benefits seen with stem cell therapy. They down regulate M1 microglia which are pro-inflammatory and up regulate M2 microglia which are anti-inflammatory. They promote T-reg cells, increase IL-10, TGF-beta 3 and TGF-beta 1. They have a recognized role in intracellular communication in both healthy and diseased tissue.

Mesenchymal stem cells (MSC) secrete exosomes. However, there are no cells in exosomes. They use paracrine signaling to regulate cell differentiation, proliferation and recruitment. More specifically a cell produces a signal to change the behavior of a nearby cell. They change the behavior and influence metabolism of other cells and send out genetic signals. They target tissues including the heart, brain, liver, lungs, intestines, skin, skeletal muscle, spinal cord and the immune system.

Derived exosomes come from umbilical cord mesenchymal stem cells.

Powerful immunologic and autoimmune diseases including Crohn’s disease, ulcerative colitis, Lupus, thyroid disorders, diabetes, PANDAS, and autoimmune after strep infections could benefit from exosome therapy. They regulate the humeral and the antibody system of the body.

Beneficial effects include orthopedics, joints, tendons, ligaments, muscles, fractures, degenerative arthritis, and rheumatoid arthritis, as well as immune issues. They are used intravenously and become systemic. Ultimately, they are considered a new tool in orthopedic medicine with stem cells and Platelet Rich Plasma (PRP).

Post heart attack patients can benefit from the reparative effect to the myocardium. Other applications include angina, congestive heart failure, cardiomyopathy, COPD and interstitial lung disease. Studies are being published now to show the beneficial factors.

Neurologically this area could show the most promise. MS, Parkinson’s, Alzheimer’s, peripheral neuropathy, Amyotrophic Lateral Sclerosis ALS, stroke, traumatic brain injury, stroke, cerebral palsy, and maybe even autism. The therapy can be applied by IV or nasal spray.

PubMed® has published 500 papers on exosomes and neurodegeneration. Research shows possible improvement of nerve communication and circuitry in the brain. This is important for all types of brain injury.

There are other application that may improve, as well, including macular degeneration (dry only as wet is contraindicated), cataracts, retinitis pigmentosa, wound healing (application by topical, IV, or injection locally for acute burns), scars, keloids, burns, liver disease, kidney disease, peripheral neuropathy, erectile dysfunction, urinary incontinence, aesthetic applications, and hair loss. The therapy provides a good scaffold for PRP.

Other conditions that can benefit include aging, senescence, inflammatory conditions, Type 2 Diabetes Mellitus, Sarcopenia, loss of muscle, poor memory, dementia, neurodegeneration, recent or old musculoskeletal injury, sexual dysfunction, obesity and metabolic syndrome, alopecia, and various aesthetic applications.

According to Dr. Magaziner dosages for IV administration are typically intra-articular: 3-5 billion, IV: 15 billion (5 cc), subcutaneous: 5 billion, Intranasal: 1 billion (mild to moderate dementia along with IV).

Dr. Magaziner also elaborated on the use of therapeutic peptides. The International Peptide Society holds a major conference every year. In addition, online courses and webinars are available to learn how to integrate these protocols into practice.

What are peptides? They are short chains of amino acids, which are usually less than 50 amino acids in length, stabilized by a disulfide bond, designed to bind and modulate protein interaction, and are highly specific. There are over 7000 naturally occurring peptides in our own bodies. They act as signaling molecules, bind to receptors on cell surfaces, and tell other cells what to do. They are well tolerated and safe. Currently there are over 60 FDA approved peptide medications, over 140 being evaluated in clinical trials, and more than 500 in preclinical development. They have a short half-life so they often need to be administered frequently.

What do they do for us? They can reduce cellular senescence, improve athletic performance, reduce inflammatory diseases, improve brain function, improve aesthetics, help with weight loss, heal injured tissue, assist in wound care, improve hormone regulation and support cancer patients.

Peptides are purchased through compounding pharmacies and are typically combined. Peptides offer a novel and promising approach to the development of anticancer agents. They can be combined with oxygen treatments, PEMF, enemas, juicing, and IV Vitamin C along for cancer. The peptides have an anti-cancer effect, vaccine similarity, are anti-allergenic, assist with neurodegenerative disease and support hormone modulation.

There are several categories of peptides. These include senolytics, growth hormone secretagogues, and SARM’s (Selective Androgen Receptor Modulators).

The benefits of peptides over proteins and antibodies include: small size, can reach all tissues, easy to synthesize and modify, high rate of specificity and selectivity, do not accumulate in specific organs so there are few side effects, less immunogenic than recombinant antibodies or proteins, and low toxicity.

One can find 500,000 papers on peptides and cancer on PubMed®. They can have various characteristics as to how they impact the body. They have different therapeutic applications depending on the peptide chosen. Some are antimicrobial (AMPs). Some are cell permeable (CPPs). Some are tumor targeting (TTPs).

Dr. Magaziner’s favorite peptides are Thymosin Alpha-1, PNC 27, iRGD and MENK. Thymosin Alpha -1 is his most favorite. It has 28 amino acids. It is normally secreted by the Thymus. It balances the Th1/Th2 immune response, improves NK cell activity and TNF-alpha, inhibits viral replication, impacts immune-deficiencies, malignancies and infections, modulates the immune system with almost no side effects, enhances dendritic cells, enhances antibody responses and protects against oxidative stress. (This peptide is also being used for COVID-19.)

It is also used for autoimmune diseases like Hashimoto’s Thyroiditis, Crohn’s Disease and Ulcerative Colitis, Hepatitis B and C, Sepsis, HIV/AIDS as an adjunct to anti-retroviral therapies, COPD/Asthma, Cancer, malignant melanoma, and is an anti-proliferative against malignant Human Hepatoma. In cancer it helps reduce the toxicity of chemo therapy and inhibits tumor cell proliferation.

Application, according to Dr. Magaziner, of peptides is subcutaneous .15 cc daily or .50 cc two times a week (3mg/cc). For viral infections, a 2 week protocol is used. Three months or longer is typical for HIV, cancer hepatitis or complicated immune suppression disorders. The FDA approved form is called Zadaxin. It can be combined with interferon for Hepatitis.

Combination therapies like combining Thymosin Alpha-1 with iRGD have shown to be synergistic for cancer.

Met-Enkphalin (MENK): It is an endogenous opioid peptide with huge impact on cell growth, stops the proliferation of cancer cells often, shows profound improvement in the lymphocytes in peripheral blood, and is a strong immune booster with the potential to restore damaged immune systems from chemo and radiation. However, MENK is hard to get now.

PNC-27 is used for cancer that displays a P53 gene mutation. 100% of actinic keratosis and 90% of all other skin cancers display this mutation so this could be beneficial for those cases. It doesn’t impact healthy cells. In solid tumors, it may induce trans-membrane pore formation resulting in cancer cell death. In vitro studies it suppresses cell proliferation and cytotoxicity compared to controls. This peptide can be applied topically with a usual dosage of .10cc subcutaneous daily (1mg/cc). Unfortunately, like MENK, this peptide is hard to get now.

IRGD is a tumor penetrating peptide. It works synergistically with TA-1 to inhibit proliferation of cancer cells in vitro. It increases anti-proliferation activity of TA-1 by improving the ability of TA-1 to penetrate the cancer cell. It improves penetration of other anti-cancer agents and inhibits cancer metastasis. The usual dosage is .15cc subcutaneous daily (40 mcg/kg, 1 month on, 1 month off). As with MENK and PNC-27, IRDG is hard to get now.

Cerebrolysin is not for cancer but helps with memory and focus. Unfortunately it is now unavailable in the US. They are now classifying it as a biologic even though it is a synthetic nootropic drug that enhances cognition. It possesses neuroprotective and neurotropic reparative properties. It penetrates the blood brain barrier and reaches neurons directly. It improves peripheral and central neuronal stimulation. The dose is usually 1 cc subcutaneous daily. But some use up to 30 cc per day. It had been used for chronic or acute pain, stroke, concussion/TBI, Parkinson’s disease, dementia/Alzheimer’s and neuropathy symptoms. It can also be used IV. FGLL and Di-hexa are two substitutes, available in cream or capsule. Di-hexa in cream or capsule (1-2 daily) is now available. Cream is applied behind the neck at bedtime. SCMAX nasal spray (1-2 daily) or subcutaneous. FGLL can be used with the Di-Hexa.

Thymosin Beta-4. This is the most abundant peptide from the thymus gland. It is present in every blood cell (with exception of RBC) and all body fluids. It is present in the nucleus, cytoplasm and extracellular space. Its’ cellular action is cell survival, cell motility, and cellular repair. It has a low molecular weight so it can travel to the site of injury. Neurologic repair would be an example. It increases cells involved in healing soft tissue, tendons, ligaments and muscles. It is anti-inflammatory, promotes angiogenesis (so avoid with active cancer patients), works in muscles to protect against sarcopenia and strengthen the heart after a heart attack. It reduces chronic and acute pain. Dosing should not exceed 3 months and cycling is recommended for long term use with 3 months on, one month off. It has immunologic effects including suppression of the production of inflammatory IL-8, and TNF-alpha. It upregulates hepatocyte growth factor and down regulates platelet-derived growth factor. It is anti-microbial, anti-inflammatory and anti-apoptotic issues. It increases oxidative enzymes to protect cells and tissues from oxidative damage. The clinical uses include scleroderma, liver fibrosis, alopecia, periodontal disease, sarcopenia, osteoarthritis, tendonitis, wound healing, cardiac (post MI), neuroprotection, autoimmune diseases, Lyme disease (also Thymosin Alpha -1), chronic fatigue and fibromyalgia, polymyalgia, NAFLD, chronic dry eye and multiple myeloma. Dr. Magaziner recommends using .25 cc/day. Eye drops are 3000 mcg/ml, 1-3 drops/daily. IV 3-6 after a TBI, MI or muscle damage. The maximum dose is 8 mg per week. This is a powerful growth factor, so do not use longer than 3 months.

BPC157 is a body protection complex. It is composed of 15 amino acid peptides and is derived from gastric juice. It is highly stable and resistant to hydrolysis and enzymatic degradation. It can be dissolved in water and given orally. It is available in topical, SQ, IM, dental paste, and eye drops. It is very repairable by upregulating growth factors. It increases expression of growth hormone receptors on tendon fibroblasts. It modulates the release of nitric oxide and stimulates angiogenesis by upregulating VEGF expression and VEGFR2. It decreases inflammatory LTB4, TXA2 and MPO. Its primary effect is cell signaling. It is very good for healing after injury. It counteracts dopamine disturbances and induces serotonin release in substantia nigra. It restores esophageal sphincter pressure after 20 months of untreated esophagitis. Can be used orally for gerd. It reduces thrombosis or bleeding/thrombocytopenia. It heals stomach ulcers, Crohn’s, NSAID injury, and intestinal permeability. It heals tendons in crush or laceration injury, periodontitis, and heals bones in six weeks. It helps with corneal injuries, deep skin burns, high histamine and low DAO, as well as multiple food intolerances. It assists in healing chronic PPI use. It also helps regulate blood pressure, vasodilation, and migraines. Dr. Magaziner uses 300 mcg SQ daily, oral capsule 500 mcg daily. It can be made into a paste for wounds. One must use caution with cancer and macular degeneration due to increased VEGF.

In general, peptides can be used subcutaneously, as transdermal creams, capsules, nasal spray and eye drops.

In the natural practice the various principles include a taking a thorough history, optimizing nutrition, removing toxins, using of appropriate supplements, utilizing IV formulations, using hyperbaric oxygen and PEMF therapies, encouraging exercise, meditation, peptide management and exosomes.

The use of exosomes and peptides is broad and is likely to become much more widely used as knowledge and education reach practitioners and clinics.

Ozone Therapy for Coronavirus

Dr Robert Rowen creates personalized treatment plans that strive to address both the symptoms and the underlying causes of disease.

Review of Dr. Robert Rowan, MD presentation

“With the exception of diet/nutrition, detoxification, and stress reduction, ozone does more good, for more conditions, than everything I have ever used in medicine combined.”

~ Robert Rowen, MD

Antibiotic resistance has caused chaos in the field of medicine. Ozone is 3 parts oxygen made by solar radiation and lightning. Ozone has a half-life of about 30 minutes. The public has been taught to be afraid of oxidants but the body holds these oxygen species in balance. These internal oxidants are essential for life and the immune system.

What is the science behind using ozone for viruses? A virus has two structures in its membrane to enter the cell. If a virus cannot enter the cell it is helpless. Lipids and proteins on the surface allow the virus to enter the cell. So the lipids and proteins are the weak link in this process. Prescriptions cannot address this but natural approaches do. Polio virus has shown to be destroyed by ozone in vitro. Research also confirms that Medical ozone has direct antiviral activity which induces long term remission and in some cases total elimination of virus from blood. Generally, ozone is a modulator of the immune system stimulating links of humoral and cell immunity.

To learn more and get training go to Ozone Without Borders.

Salicinium and Synergy for Integrative Cancer Treatments

Dr. Virginia Van Schaefer has practiced medicine and surgery for over 25 years. She is now a retired general, vascular and trauma surgeon who has been providing bio-integrative consultations to patients of all ages in a variety of clinical settings.

Review of Virginia Van Schaefer, MD presentation

In search for new answers for cancer, tests have come a long way. Now you can test for nagalase to monitor how aggressive the cancer is. Once cells lose contact with each other the cancer can proliferate. Circulating tumor cells can live 20 years.

One option to address cancer is with Salicinium which is a complex glycome which is a sugar attached to a benzadehyde ring. It works on sick cells only. Ultimately it stimulates natural killer cells. When Nagalase is held at bay, the body can use it’s natural GcMAF. In order to support this action cancer patients should avoid ozone, H2O2, oxidative therapies and excess Vitamin C. However there are many compatible therapies to use with Salicinium including glutathione, Myers Cocktail, hyperbaric oxygen, EDTA, IPT and ERT. Synergistic therapies include mistletoe, hyperthermia, Gallium Maltolate, ALT, RGCC and cell vaccine.

There is one caveat when using Salicinium in your practice with patients. As it works to eliminate the cancer, the tumor mass can puff up as it dies. Therefore, with oral cancers, brain tumors, liver tumors, and pancreatic tumors exceptional caution should be exercised. Most importantly, work with a practitioner who has had experience with Salicinium in therapy.

Navigating Through the Patient’s Life with Chronic Disease

Board-certified otolaryngologist Dr. Constantine Kotsanis is the medical director of the Kotsanis Institute for Functional Medicine in Grapevine, TX.

Review of Dr. Constantine “Gus” Kotsanis presentation

There are fundamental differences between Western Medicine and Functional Medicine. Western Medicine believes:

  1. Cancer is a localized disease;
  2. Cancer can be cured with chemotherapy, surgery, and radiation;
  3. Cancer is familial or genetic;
  4. Cancer is primarily a physical disease.

Functional Medicine believes:

  1. Cancer is a systemic disease;
  2. Cancer can be managed and controlled by many modalities;
  3. Cancer is primarily a metabolic disorder;
  4. Cancer is primarily an emotional disease.

Western Medicine adheres to the quantitative model which is the only method acceptable. It only allows the proof of laboratory and mathematically proven physical evidence for burden of proof. This method from 1910 to the present is the only accepted scientific method which involves double blind placebo studies.

Functional medicine is qualitative and has an 8,000 year history which was the predominate methodology used up to 1910 to provide scientific concept. The scientist or researcher made clinically relevant observations. The integrity of the research is what makes this form of reporting scientific. Today the term anecdotal is assigned to this but in the eyes of the functional medicine practitioner this term carries undue lack of credibility in Western Medicine.

In the evaluation of the patient’s life there are many factors that are investigated and reviewed.

  1. Nutrition
  2. Emotional stability and brain integrity
  3. Gastrointestinal integrity
  4. Voltage
  5. Endocrine integrity
  6. Endothelial integrity
  7. Immune integrity
  8. Oxidative medicine including IPT, ozone, Vitamin C, lasers, Curcumin and Methylene Blue
  9. Detoxification including Emotional detox and physical detox
  10. Regenerative medicine including stem cell technologies
  11. Family and work relationships
  12. Maintenance program and permanent life style changes

In the beginning Dr. Kontsanis looks at old emotional trauma, digestive issues, inflammation, nutrition, hormones and metabolism, voltage, and detoxing especially heavy metals. He has found that minerals are essential. Inflammation starts in the gut but can affect the brain knowing that the gut and the brain are on the same informational highway. Once all the evaluations reveal the status of the patient a plan to address each deficiency is developed.

Some simple examples for nutrition would include clean water, minerals and vitamins, balanced amino acids, digestive enzymes, and fermented foods. He pointed out that even though berries are labeled “organic,” they have often been contaminated with bromide.

Examples of detox therapies include drinking charged water, eating organic foods, chelation, oxygen therapies including EWAT, ozone, UVB, HBOT, Saunas, and photodynamic therapy. He also uses hyperthermia, homeopathic remedies, essential oils and voltage support.

For IV support he uses Myers Cocktail, UVB, H2O2, colloidal silver, NAD, curcumin, and others.

It is a functional medicine approach and is patient-specific adhering to the principles covered at the beginning of the presentation regarding the differences in the two methods.

Conclusion

This has been a review of several of the presentations at the Best Answer for Cancer.

About the Author

Joanne Quinn

Executive Director of the Foundation for Alternative and Integrative Medicine

Joanne Quinn, Ph.D., R.M.A., has an extensive background in science with a doctorate in holistic nutrition. She has studied both allopathic and alternative approaches to health care, studying alternative therapies since 1989.